Back
The Bancorp Vs. Akero Therapeutics Industry Stock Comparison
Buy
82
TBBK
The Bancorp
Last Price:
39.99
Seasonality Move:
4.62%
Buy
59
AKRO
Akero Therapeutics
Last Price:
17.90
Seasonality Move:
-0.92%
Buy
82
The Bancorp (TBBK)
is a Buy
Is The Bancorp a Buy, Sell or Hold?
- The current The Bancorp [TBBK] share price is $39.99. The Score for TBBK is 82, which is 64% above its historic median score of 50, and infers lower risk than normal.
- TBBK is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
Buy
59
Akero Therapeutics (AKRO)
is a Buy
Is Akero Therapeutics a Buy, Sell or Hold?
- The current Akero Therapeutics [AKRO] share price is $17.91. The Score for AKRO is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- AKRO is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TBBK Stock Price Chart
What is The Bancorp's stock price today?
-
The The Bancorp share price today is $39.99
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBBK is experiencing buying pressure, which is a positive indicator for future bullish movement.
AKRO Stock Price Chart
What is Akero Therapeutics's stock price today?
-
The Akero Therapeutics share price today is $17.91
The current trend is relatively stagnant and AKRO is experiencing slight selling pressure.
TBBK Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.86 | Buy |
| Relative Strength Index (14 RSI): | 63.62 | Buy |
| Chaikin Money Flow: | 445199 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
AKRO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.71 | Sell |
| Relative Strength Index (14 RSI): | 53.25 | Buy |
| Chaikin Money Flow: | -55617 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.57 - 16.71) | Buy |
| Bollinger Bands (100): | (18.32 - 50.24) | Sell |
TBBK Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 38.98 | Buy |
| 20-day SMA: | 38.76 | Buy |
| 50-day SMA: | 36.18 | Buy |
| 200-day SMA: | 33.93 | Buy |
| 8-day EMA: | 39.13 | Buy |
| 20-day EMA: | 38.43 | Buy |
| 50-day EMA: | 37.12 | Buy |
| 200-day EMA: | 34.2 | Buy |
AKRO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.73 | Buy |
| 20-day SMA: | 15.69 | Buy |
| 50-day SMA: | 21.8 | Sell |
| 200-day SMA: | 39.48 | Sell |
| 8-day EMA: | 16.85 | Buy |
| 20-day EMA: | 16.52 | Buy |
| 50-day EMA: | 21.96 | Sell |
| 200-day EMA: | 34.46 | Sell |
The Bancorp Earnings Growth & TBBK Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.33 per share, and an increase next year of $0.70 per share.
Akero Therapeutics Earnings Growth & AKRO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.43 per share, and a decrease next year of $0.77 per share.
The Bancorp Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Akero Therapeutics Technical Analysis
| Nov 20 | Nov 21 | Nov 22 | Nov 24 | Nov 27 | Nov 28 | Nov 29 | Nov 30 | Dec 1 | Dec 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 20 | 21 | 22 | 24 | 27 | 28 | 29 | 30 | 01 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||